Preoperative concurrent chemotherapy with accelerated hyperfractionated radiotherapy in non-small-cell lung cancer;: feasibility, toxicity and long-term results of a phase II study

被引：0
|
作者：
Casas, F.
Vinolas, N.
Marruecos, J.
Carcereny, E.
Jorcano, S.
Gimferrer, J. M.
Marrades, R.
Luburich, P.
Agusti, C.
机构：
[1] Hosp Clin Barcelona, Radiat Oncol ICMHO, Barcelona, Spain
[2] Hosp Clin Barcelona, Lung Canc Comm, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [21] PHASE-II STUDY OF CONCURRENT RADIOTHERAPY AND CHEMOTHERAPY FOR UNRESECTABLE STAGE-III NON-SMALL-CELL LUNG-CANCER
    FURUSE, K
    KUBOTA, K
    KAWAHARA, M
    KODAMA, N
    OGAWARA, M
    AKIRA, M
    NAKAJIMA, S
    TAKADA, M
    KUSUNOKI, Y
    NEGORO, S
    MATSUI, K
    MASUDA, N
    TAKIFUJI, N
    KUDOH, S
    NISHIOKA, M
    FUKUOKA, M
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 869 - 875
  • [22] Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up
    Parisi, Elisabetta
    Genestreti, Giovenzio
    Sarnelli, Anna
    Ghigi, Giulia
    Arpa, Donatella
    Burgio, Marco Angelo
    Gavelli, Giampaolo
    Rossi, Alice
    Scarpi, Emanuela
    Monti, Manuela
    Tesei, Anna
    Polico, Rolando
    Romeo, Antonino
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [23] Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up
    Elisabetta Parisi
    Giovenzio Genestreti
    Anna Sarnelli
    Giulia Ghigi
    Donatella Arpa
    Marco Angelo Burgio
    Giampaolo Gavelli
    Alice Rossi
    Emanuela Scarpi
    Manuela Monti
    Anna Tesei
    Rolando Polico
    Antonino Romeo
    Radiation Oncology, 14
  • [24] Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.
    Jeremic, B
    Milicic, B
    Acimovic, L
    Milisavljevic, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 657S - 657S
  • [25] Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902
    Kubota, K
    Tamura, T
    Fukuoka, M
    Furuse, K
    Ikegami, H
    Ariyoshi, Y
    Kurita, Y
    Saijo, N
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 445 - 450
  • [26] Patient-reported short-term and long-term physical and psychologic symptoms: Results of the continuous hyperfractionated accelerated radiotherapy (CHART) randomized trial in non-small-cell lung cancer
    Bailey, AJ
    Parmar, MKB
    Stephens, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 3082 - 3093
  • [27] LONG-TERM RESULTS OF COMBINED TREATMENT WITH POSTOPERATIVE ACCELERATED HYPERFRACTIONATED RADIOTHERAPY IN OPERABLE LUNG CANCER
    Ragulin, Y. A.
    Mardynsky, Y. S.
    Medvedev, V. N.
    Kudryavtsev, D. V.
    Kursova, L. V.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S55 - S56
  • [28] Toxicity of Hypofractionated Accelerated Radiotherapy Concurrent with Chemotherapy for Non-small Cell Carcinoma of the Lung
    Carruthers, R.
    O'Rourke, N.
    Mohammed, N.
    Hicks, J.
    Brisbane, I.
    CLINICAL ONCOLOGY, 2011, 23 (08) : 561 - 562
  • [29] Randomized Phase 3 Study Of Concurrent Cisplatin with Pemtrexed Or Vinorelbine And Late Course Accelerated Hyperfractionated Radiotherapy For Unresectable Stage 3 Non-small-cell Lung Cancer
    Li, B.
    Wu, Z.
    Wang, Z.
    Wang, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S208 - S208
  • [30] Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer
    Wada, Kentaro
    Kishi, Noriko
    Kanayama, Naoyuki
    Hirata, Takero
    Morimoto, Masahiro
    Konishi, Koji
    Imamura, Fumio
    Teshima, Teruki
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2018, 38 (10) : 5951 - 5958
12345